Back

Results - Announcements

Sales decline 37.43% to Rs 29.61 crore

Medicamen Biotech consolidated net profit rises 13.62% in the March 2025 quarter

31-May-2025, 12:19
Net profit of Medicamen Biotech rose 13.62% to Rs 2.42 crore in the quarter ended March 2025 as against Rs 2.13 crore during the previous quarter ended March 2024. Sales declined 37.43% to Rs 29.61 crore in the quarter ended March 2025 as against Rs 47.32 crore during the previous quarter ended March 2024.

For the full year,net profit declined 34.95% to Rs 7.11 crore in the year ended March 2025 as against Rs 10.93 crore during the previous year ended March 2024. Sales declined 9.35% to Rs 162.55 crore in the year ended March 2025 as against Rs 179.31 crore during the previous year ended March 2024.

Particulars	Quarter Ended			Year Ended
	Mar. 2025	Mar. 2024	% Var.	Mar. 2025	Mar. 2024	% Var.
Sales	29.61	47.32	-37	162.55	179.31	-9
OPM %	-5.44	12.15	-	8.53	12.40	-
PBDT	2.97	4.43	-33	16.95	20.17	-16
PBT	2.49	2.66	-6	9.88	13.08	-24
NP	2.42	2.13	14	7.11	10.93	-35